CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Endo International PLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Endo International PLC High Risk Report!
Minerva House, Simmonscourt Road
Phone: +353 12682000p:+353 12682000 DUBLIN, 000 00  Ireland
Filed for Bankruptcy on 8/16/2022
Case #22-22549, filed in the U.S. Bankruptcy Court for the Southern District of New York (White Plains)
On 3/22/2024, the Court entered an order approving Endo International PLC’s (EIP) plan of reorganization (the “Plan”), including the sale of substantially all of EIP’s assets to Endo, Inc., a newly formed entity. On 4/23/2024, Endo, Inc. completed the acquisition, which rendered the Plan effective. As a result, EIP’s operating assets have successfully exited the Chapter 11 financial restructuring process.
This entity represents the bankrupt estate of the former business (assets) of Endo International PLC that were not acquired by newly formed, Endo Inc., on 4/23/2024.
This company is no longer actively traded on any major stock exchange.
Business Summary
Endo International plc has filed a voluntary petition under Chapter 11 of the U.S. Bankruptcy Code and is winding down its business. The Company has no business operations.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023YesYesYesYesYes

Industries
SIC Code Description
2834 Pharmaceutical preparations
6726 Unit investment trusts, face-amount certificate offices

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Non-Executive Chairman of the Board Mark G.Barberio 61 6/10/2021 2/19/2020
President, Chief Executive Officer, Director BlaiseColeman 49 3/6/2020 11/22/2016
Chief Financial Officer, Executive Vice President Mark T.Bradley 54 3/6/2020 3/6/2020
9 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 235,219,612 (As of 2/28/2024)
Shareholders: 199
Stock Exchange: OTC
Federal Tax Id: 680683755


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, November 10, 2024